Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multiple-dose Tolerability and Pharmacokinetic Studies of Benapenem for Injection in Phase Ib Clinical Healthy Subjects

NCT03570970 is registered in ClinicalTrials.gov with Sihuan Pharmaceutical Holdings Group Ltd. as lead sponsor.

NCT NCT03570970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03570970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multiple-dose Tolerability and Pharmacokinetic Studies of Benapenem for Injection in Phase Ib Clinical Healthy Subjects
Lead sponsor
Sihuan Pharmaceutical Holdings Group Ltd.
Phase
Phase 1
Overall status
Completed
Start date
March 14, 2016
Completion date
June 2, 2016
Enrollment
36 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy subject